NORTHBAY HOSPITAL GROUP — History
CCN 050367 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$677M
Latest Revenue (FY2022)
+7.5%
Revenue CAGR (3yr)
-8.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $586M | $660M | $677M | +2.5% | +7.5% |
| Operating Expenses | $627M | $692M | $732M | +5.7% | +8.0% |
| Operating Margin | -7.0% | -4.9% | -8.2% | -68.2% | +0.0% |
| Net Income | $-41M | $-32M | $-55M | -72.3% | +0.0% |
| Licensed Beds | 182 | 204 | 204 | +0.0% | +5.9% |
| Total Patient Days | 44,469 | 52,992 | 52,773 | -0.4% | +8.9% |
| Medicare Day % | 40% | 38% | 34% | -8.8% | -7.9% |
| Medicaid Day % | 8% | 7% | 6% | -8.7% | -12.6% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.5% ($586M → $677M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-8.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $722M | -8.7% |
| FY2024 (proj) | $767M | -9.3% |
| FY2025 (proj) | $813M | -9.9% |